Investigating Participation Patterns Among Stage IV Melanoma Patients

Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06093594

Enrollment

500

Registered

2023-10-23

Start date

2024-11-30

Completion date

2026-11-30

Last updated

2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IV Melanoma

Keywords

Stage IV Melanoma

Brief summary

Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Aged ≥ 18 years old * Diagnosis of stage IV melanoma * Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

* Female patients who are currently pregnant or nursing * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial. * Inability to perform regular electronic reporting

Design outcomes

Primary

Measure	Time frame
Number of stage IV melanoma patients who decide to enroll in a clinical research	3 months
Rate of stage IV melanoma patients who remain in clinical trial to trial completion	12 months

Countries

United States

Contacts

Primary ContactMichael B Gill

bask@withpower.com415-900-4227

Outcome results